Oncology

A Clinical Study for Stage III Pancreatic Cancer

Physician Finder

Choosing to participate in a clinical study is an important personal decision. Please speak with your doctor and/or family members about your options.

To find a doctor near you that is participating in the DIRECT study, use the Physician Finder below.

If you would like to learn more about the DIRECT study, please call our DIRECT study support line at +1 (800) 584-7608.

or
3 Physicians located who are associated with DIRECT Study.
Alexander Y. Kim, MD
  • Specialty
    Oncology
  • Location
    3800 Reservoir Rd NW
    Washington, DC 20007
  • Phone
    (202) 444-3450
More
Robert C.G. Martin, MD, PhD
  • Specialty
    Oncology
  • Location
    315 E. Broadway
    M10 - Rm#311
    Louisville, KY 40202
  • Phone
    502-629-3355

Physician Bio

Dr. Robert C.G. Martin, MD, PhD, Hepato-Pancreatico-Biliary and Surgical Oncology at the University of Louisville

Dr. Robert C. G. Martin has been a pioneer in IRE clinical use and outcomes. He performed the first case of IRE in the pancreas in 2009 and has performed over 325 cases since then,  He has published over 20 peer review manuscripts in IRE of the pancreas and liver. He is Director of the Division of Surgical Oncology, Department of Surgery, at the University of Louisville School of Medicine. Dr. Martin has been a leader in multidisciplinary cancer patient care and is responsible for many advances at the University of Louisville. His areas of interest include liver tumors (ablations, laparoscopic and open resections), pancreatic, gastric and colon cancers Dr. Robert C.G. Martin, MD, PhD, Hepato-Pancreatico-Biliary and Surgical Oncology at the University of Louisville(laparoscopic and open surgery), esophageal cancer (laparoscopic, open and endoscopic stenting and ablation), bile duct tumors, sarcoma and melanoma. Dr. Martin received his M.D. from the University of Louisville School of Medicine and his surgical oncology training and hepatopancreatic-biliary training from Memorial Sloan-Kettering Cancer Center, and his PhD from the Department of Pharmacology and Toxicology at the University of Louisville School of Medicine.


More
Govindarajan Narayanan, MD
  • Specialty
    Oncology
  • Location
    8900 N Kendall Drive
    Miami, FL 33176

Physician Bio

Renowned Interventional radiologist Govindarajan Narayanan, M.D., is a part of two of Baptist Health South Florida’s premiere service lines – Miami Cardiac and Vascular Institute, the area’s largest and most comprehensive cardiovascular facility, and Miami Cancer Institute, a next-generation cancer center and Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, where he serves as the Chief of Interventional Oncology. He is a Professor of Radiology at the Florida International University, Herbert Wertheim College of Medicine

Dr. Narayanan has a wealth of academic, clinical and research expertise. He was the founding chair of the Department of Interventional Radiology at the University of Miami Leonard M. Miller School of Medicine and held the titles of Professor of Interventional Radiology and Professor of Urology. A member of numerous professional and honorary organizations, he is also a pioneer in his field, developing the technique of percutaneous irreversible electroporation (IRE) of the pancreas.

Dr. Narayanan is board-certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology. He is widely published in prestigious medical journals such as Cancer, Journal of Vascular and Interventional Radiology and Cardiovascular & Interventional Radiology and serves as a reviewer and editor for several scientific publications. His published work on Percutaneous IRE of the pancreas was honored as a distinguished study of the year at the 2018 Society of Interventional Radiology Annual meeting. He also is an invited faculty member and speaker at several national and international scientific meetings.

Dr. Narayanan’s primary clinical and research interests include pancreatic, liver and colon cancer.


More